In a recent study posted to the bioRxiv* preprint server, researchers demonstrated severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) evolution at the transcriptional level. Study:...
In a recent study posted to the bioRxiv* preprint server, researchers investigated variations in the host immune response-elicited by non-structural protein 1 (nsp1) of coronaviruses...
Please can you introduce yourself, tell us about your background in medical informatics, and what inspired your latest research into identifying independent variants that significantly...
In a recent study posted to the bioRxiv* preprint server, researchers developed an immunoantiviral, NanoSTING, and demonstrated its broad-spectrum antiviral properties in hamsters and mice....
Northwestern Medicine investigators have discovered a novel signaling pathway activated by interferons, a group of immune system proteins, that suppresses the anti-tumor response of interferons...
In a recent study published on the bioRxiv* preprint server, researchers demonstrate that avasimibe (AVS)-mediated inhibition of Acyl-CoA: cholesterol acyltransferase (ACAT) blocks the entry and...
Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) that led to the coronavirus disease 2019 (COVID-19) pandemic can cause various clinical presentations ranging...
If you’re relying on nasal or throat-based tests to give you a clean bill of health after a COVID-19 infection, you might be swabbing the...
In a recent study under consideration at Nature Portfolio Journal and posted to the Research Square* preprint server, researchers demonstrated the evolution of multi-system inflammatory...
A recent article posted to the bioRxiv* preprint server illustrated that the activation of the Hippo signaling pathway upon severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)...
A recent article posted to the bioRxiv* preprint server presented a safe and efficient multi-epitope severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine construct against SARS-CoV-2...
As of April 3, 2022, coronavirus disease 2019 (COVID-19) has caused almost 6.2 million deaths worldwide. While in many developed nations, life is beginning to...
